Active Tau Vaccine Expands Phase 1 Trial Size
AADvac1 has shown potential in preventing the progress of neuropathies and Alzheimer's disease.
Read More
FDA Approves Mepolizumab (Nucala) for EPGA
The subcutaneous injection was previously approved for severe asthma with an eosinophilic phenotype.
Diabetes, High BMI Correlation with Greater Cancer Risks
The study found that 5.6% of all incident cancers from 5 years ago were attributable to the combined effects of diabetes and high BMI.
Majority of College Students Don't Get Flu Vaccine
The strong rate of young adults who refrain from the vaccine contrast a reported majority that believe the vaccine is important to get.
Physicians Face the Burden of the Anti-vaccination Argument
Public perception of doctors has changed, and so has the effort physicians must put into getting through to difficult patients.
US Health Care Spending Reached $3.3 Trillion in 2016
The growth rate of 4.3% was actually a drop in previous years' rates, but could be indicative of a return to norm.
Researchers Uncover Varying Antibiotic Chemical Species
Common tuberculosis therapy D-cycloserine has shown to have second chemical action when combating bacteria enzymes.
FDA Approves Semaglutide (OZEMPIC) for T2D Glycemic Control
OZEMPIC, a GLP-1 receptor agonist, was tested in 2-year cardiovascular outcome trials.
More Than Half of Children Projected to Be Obese By Age 35
The projection based study found strong correlations between childhood and adulthood obesity.
Liver MRI Device Provides Non-invasive Diagnostics
The LiverMultiScan can quantify liver fat, and is compatible with MRI devices.
CVS Eyes Localized Health Care With $69 Billion Aetna Purchase
CVS Health currently operates about 9,700 retail locations, 1,100-plus walk-in medical clinics, and has almost 90 million plan members.
Stale Bread: Considering the Problems of Telehealth
The telehealth market is growing in rural areas. But one psychiatry specialist is not interested in its offerings.
Ketamine Strengthens Antidepressant Case in 2017
The longtime anesthetic has shown strong, fast-acting efficacy in drug-resistant MDD patients.
FDA Shares Congress-inspired Regulatory Changes
Commissioner Scott Gottlieb, MD, testified the changes that followed the 21st Century Cures Act.
FDA Approves ISENTRESS For HIV-1 Newborns
The integrase inhibitor raltegravir serves as a combination therapy with ART regimens.
NIH Researchers Call For Comprehensive Pandemic Preparations
The essay authors look back at previous reactions and responses to major pathogens.
Novel, Natural Eczema Cream Gets FDA Approval
The New Zealand-based over-the-counter therapy will be available for US patients on Amazon's website in 2018.
Trelegy Ellipta Seeks COPD Expanded Indication
The first once-daily, triple-therapy inhaler drug was originally approved by the FDA in September.
What Individualizing T2D Care Looks Like
With a dozen-plus agent classes for diabetes, what do physicians address first in patients?
Self-harm, Suicide on the Rise in US Youths
Young people's ED visits for nonfatal self-inflicted injuries increased nearly 6% annually since 2008.
Tardive Dyskinesia Biomarkers Found in Blood Serum
Brain-derived neurotrophic factor, interleukin 6, and S100-beta concentration levels were consistent in tested TD patients.
The Connected Clinician: Top Stories of the Week for November 25
Stay connected and up-to-date in health care news with the Connected Clinician top stories of the week for the week of November 25.
Gut Bacteria Could Cause MS in Younger Patients
Mouse models engineered with MS-associated risk genes developed an equivalent MS condition and bowel inflammation after being exposed to an environment with bacteria present.
Stem Cell Deletion Improves TBI Recovery in Mice
In deleting the gene encoding of SOX2 in models inflicted with TBI, functional and behavioral recovery improved.
Common Malaria Drug Prevents Zika Pregnancy Transmission
Chloroquine could serve as an endemic response to Zika in lieu of a vaccination.
FDA Sets New Opioid Generics Guidelines
The guidelines are intended to expedite and broaden the abuse-deterrent opioid generics market.
Hemlibra Shows More Hemophilia A Efficacy After FDA Approval
Genentech's prophylaxis has the potential for further indications in adult and pediatric patients with hemophilia A.
Ingrezza Improves TD Symptoms In Year-long Extension
In 2 different dose groups, patients reported gradual decreases in AIMS scores over 42 weeks.
Antibody Analysis Could Lead to Strengthened Malaria Vaccine
Researchers continue to seek means to improve the efficacy and tolerability of the RTS,S vaccine.
The Connected Clinician: Top Stories of the Week for November 18
Stay connected and up-to-date in health care news with the Connected Clinician top stories of the week for the week of November 18.